823 related articles for article (PubMed ID: 32268905)
21. Competing-risks model for prediction of small-for-gestational-age neonate from biophysical and biochemical markers at 11-13 weeks' gestation.
Papastefanou I; Wright D; Syngelaki A; Souretis K; Chrysanthopoulou E; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Jan; 57(1):52-61. PubMed ID: 33094535
[TBL] [Abstract][Full Text] [Related]
22. Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE.
Tan MY; Poon LC; Rolnik DL; Syngelaki A; de Paco Matallana C; Akolekar R; Cicero S; Janga D; Singh M; Molina FS; Persico N; Jani JC; Plasencia W; Greco E; Papaioannou G; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2018 Jul; 52(1):52-59. PubMed ID: 29704277
[TBL] [Abstract][Full Text] [Related]
23. Effect of routine first-trimester combined screening for pre-eclampsia on small-for-gestational-age birth: secondary interrupted time series analysis.
Guy GP; Leslie K; Diaz Gomez D; Forenc K; Buck E; Bhide A; Thilaganathan B
Ultrasound Obstet Gynecol; 2022 Jan; 59(1):55-60. PubMed ID: 34319638
[TBL] [Abstract][Full Text] [Related]
24. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.
Duhig KE; Myers J; Seed PT; Sparkes J; Lowe J; Hunter RM; Shennan AH; Chappell LC;
Lancet; 2019 May; 393(10183):1807-1818. PubMed ID: 30948284
[TBL] [Abstract][Full Text] [Related]
25. Distinctive patterns of placental lesions in pre-eclampsia vs small-for-gestational age and their association with fetoplacental Doppler.
Paules C; Youssef L; Rovira C; Crovetto F; Nadal A; Peguero A; Figueras F; Eixarch E; Crispi F; Miranda J; Gratacós E
Ultrasound Obstet Gynecol; 2019 Nov; 54(5):609-616. PubMed ID: 31115105
[TBL] [Abstract][Full Text] [Related]
26. Customized birth-weight centiles and placenta-related fetal growth restriction.
Melamed N; Hiersch L; Aviram A; Keating S; Kingdom JC
Ultrasound Obstet Gynecol; 2021 Mar; 57(3):409-416. PubMed ID: 33073889
[TBL] [Abstract][Full Text] [Related]
27. Planned early delivery versus expectant management of the term suspected compromised baby for improving outcomes.
Bond DM; Gordon A; Hyett J; de Vries B; Carberry AE; Morris J
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009433. PubMed ID: 26599471
[TBL] [Abstract][Full Text] [Related]
28. Association between antenatal diagnosis of late fetal growth restriction and educational outcomes in mid-childhood: A UK prospective cohort study with long-term data linkage study.
Olga L; Sovio U; Wong H; Smith G; Aiken C
PLoS Med; 2023 Apr; 20(4):e1004225. PubMed ID: 37093852
[TBL] [Abstract][Full Text] [Related]
29. Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):203-9. PubMed ID: 26224608
[TBL] [Abstract][Full Text] [Related]
30. Comparison between three-dimensional placental volume at 12 weeks and uterine artery impedance/notching at 22 weeks in screening for pregnancy-induced hypertension, pre-eclampsia and fetal growth restriction in a low-risk population.
Hafner E; Metzenbauer M; Höfinger D; Stonek F; Schuchter K; Waldhör T; Philipp K
Ultrasound Obstet Gynecol; 2006 Jun; 27(6):652-7. PubMed ID: 16514618
[TBL] [Abstract][Full Text] [Related]
31. Placental growth fActor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspecTed pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2).
Hurrell A; Sparkes J; Duhig K; Seed PT; Myers J; Battersby C; Clark K; Green M; Hunter RM; Shennan AH; Chappell LC; Webster L
Trials; 2022 Sep; 23(1):722. PubMed ID: 36056408
[TBL] [Abstract][Full Text] [Related]
32. Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort study.
Sovio U; White IR; Dacey A; Pasupathy D; Smith GCS
Lancet; 2015 Nov; 386(10008):2089-2097. PubMed ID: 26360240
[TBL] [Abstract][Full Text] [Related]
33. A clinical evaluation of placental growth factor in routine practice in high-risk women presenting with suspected pre-eclampsia and/or fetal growth restriction.
Ormesher L; Johnstone ED; Shawkat E; Dempsey A; Chmiel C; Ingram E; Higgins LE; Myers JE
Pregnancy Hypertens; 2018 Oct; 14():234-239. PubMed ID: 29559205
[TBL] [Abstract][Full Text] [Related]
34. Antiplatelet agents for preventing pre-eclampsia and its complications.
Duley L; Meher S; Hunter KE; Seidler AL; Askie LM
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684684
[TBL] [Abstract][Full Text] [Related]
35. Placental size and the prediction of severe early-onset intrauterine growth restriction in women with low pregnancy-associated plasma protein-A.
Proctor LK; Toal M; Keating S; Chitayat D; Okun N; Windrim RC; Smith GC; Kingdom JC
Ultrasound Obstet Gynecol; 2009 Sep; 34(3):274-82. PubMed ID: 19672838
[TBL] [Abstract][Full Text] [Related]
36. Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia.
Kovo M; Schreiber L; Elyashiv O; Ben-Haroush A; Abraham G; Bar J
Reprod Sci; 2015 Mar; 22(3):316-21. PubMed ID: 25001023
[TBL] [Abstract][Full Text] [Related]
37. Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age.
Garcia-Manau P; Mendoza M; Bonacina E; Garrido-Gimenez C; Fernandez-Oliva A; Zanini J; Catalan M; Tur H; Serrano B; Carreras E
Acta Obstet Gynecol Scand; 2021 Jan; 100(1):119-128. PubMed ID: 32860218
[TBL] [Abstract][Full Text] [Related]
38. Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks' gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study.
MacDonald TM; Tran C; Kaitu'u-Lino TJ; Brennecke SP; Hiscock RJ; Hui L; Dane KM; Middleton AL; Cannon P; Walker SP; Tong S
BMC Pregnancy Childbirth; 2018 Aug; 18(1):354. PubMed ID: 30170567
[TBL] [Abstract][Full Text] [Related]
39. Placental Growth Factor informed management of suspected pre-eclampsia or fetal growth restriction: The MAPPLE cohort study.
Sharp A; Chappell LC; Dekker G; Pelletier S; Garnier Y; Zeren O; Hillerer KM; Fischer T; Seed PT; Turner M; Shennan AH; Alfirevic Z
Pregnancy Hypertens; 2018 Oct; 14():228-233. PubMed ID: 29627351
[TBL] [Abstract][Full Text] [Related]
40. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
Vayssière C; Sentilhes L; Ego A; Bernard C; Cambourieu D; Flamant C; Gascoin G; Gaudineau A; Grangé G; Houfflin-Debarge V; Langer B; Malan V; Marcorelles P; Nizard J; Perrotin F; Salomon L; Senat MV; Serry A; Tessier V; Truffert P; Tsatsaris V; Arnaud C; Carbonne B
Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
